These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32033849)

  • 61. Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees.
    Dagan R; Sikuler-Cohen M; Zamir O; Janco J; Givon-Lavi N; Fraser D
    Pediatr Infect Dis J; 2001 Oct; 20(10):951-8. PubMed ID: 11642629
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Estimated severe pneumococcal disease cases and deaths before and after pneumococcal conjugate vaccine introduction in children younger than 5 years of age in South Africa.
    von Mollendorf C; Tempia S; von Gottberg A; Meiring S; Quan V; Feldman C; Cloete J; Madhi SA; O'Brien KL; Klugman KP; Whitney CG; Cohen C
    PLoS One; 2017; 12(7):e0179905. PubMed ID: 28671978
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Imputing the Direct and Indirect Effectiveness of Childhood Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease by Surveying Temporal Changes in Nasopharyngeal Pneumococcal Colonization.
    Nzenze SA; Madhi SA; Shiri T; Klugman KP; de Gouveia L; Moore DP; Karstaedt AS; Tempia S; Nunes MC; von Gottberg A
    Am J Epidemiol; 2017 Aug; 186(4):435-444. PubMed ID: 28482004
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effectiveness of three pneumococcal conjugate vaccines (PCV) to prevent invasive pneumococcal disease in Quebec, Canada.
    Cané A; Hamelin B; Isturiz R
    Vaccine; 2016 Apr; 34(18):2051-2. PubMed ID: 26235371
    [No Abstract]   [Full Text] [Related]  

  • 65. Effectiveness of pneumococcal conjugate vaccine in infants by maternal influenza vaccination status.
    van Santen KL; Bednarczyk RA; Adjaye-Gbewonyo D; Orenstein WA; Davis R; Omer SB
    Pediatr Infect Dis J; 2013 Nov; 32(11):1180-4. PubMed ID: 23856786
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pneumococcal meningitis before the introduction of 10-valent pneumococcal conjugate vaccine into the National Childhood Immunization Program in Poland.
    Polkowska A; Skoczyńska A; Paradowska-Stankiewicz I; Stefanoff P; Hryniewicz W; Kuch A; Lyytikäinen O; Nuorti JP
    Vaccine; 2019 Feb; 37(10):1365-1373. PubMed ID: 30638798
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Declining Trends of Pneumococcal Meningitis in Gambian Children After the Introduction of Pneumococcal Conjugate Vaccines.
    Sanneh B; Okoi C; Grey-Johnson M; Bah-Camara H; Kunta Fofana B; Baldeh I; Papa Sey A; Labbo Bah M; Cham M; Samateh A; Usuf E; Ndow PS; Senghore M; Worwui A; Mwenda JM; Kwambana-Adams B; Antonio M
    Clin Infect Dis; 2019 Sep; 69(Suppl 2):S126-S132. PubMed ID: 31505634
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Impact of 10- and 13-valent pneumococcal conjugate vaccines on incidence of invasive pneumococcal disease in children aged under 16 years in Germany, 2009 to 2012.
    Weiss S; Falkenhorst G; van der Linden M; Imohl M; von Kries R
    Euro Surveill; 2015 Mar; 20(10):21057. PubMed ID: 25788255
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Estimated effect of pneumococcal conjugate vaccination on invasive pneumococcal disease and associated mortality, Denmark 2000-2005.
    Harboe ZB; Valentiner-Branth P; Benfield TL; Christensen JJ; Hjuler T; Kaltoft M; Krogfelt KA; Lambertsen L; Konradsen HB
    Vaccine; 2008 Jul; 26(29-30):3765-71. PubMed ID: 18513840
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Long-term Impact of Pneumococcal Conjugate Vaccines on Invasive Disease and Pneumonia Hospitalizations in Indigenous and Non-Indigenous Australians.
    Meder KN; Jayasinghe S; Beard F; Dey A; Kirk M; Cook H; Strachan J; Sintchenko V; Smith H; Giele C; Howden B; Krause V; Mcintyre P
    Clin Infect Dis; 2020 Jun; 70(12):2607-2615. PubMed ID: 31388670
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cost-effectiveness analysis of pneumococcal vaccination for infants in China.
    Maurer KA; Chen HF; Wagner AL; Hegde ST; Patel T; Boulton ML; Hutton DW
    Vaccine; 2016 Dec; 34(50):6343-6349. PubMed ID: 27810315
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Physician perspectives regarding pneumococcal conjugate vaccine.
    Schaffer SJ; Szilagyi PG; Shone LP; Ambrose SJ; Dunn MK; Barth RD; Edwards K; Weinberg GA; Balter S; Schwartz B
    Pediatrics; 2002 Dec; 110(6):e68. PubMed ID: 12456935
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pediatric hospitalization for pneumococcal diseases preventable by 7-valent pneumococcal conjugate vaccine in Hong Kong.
    Ho PL; Chiu SS; Chow FK; Mak GC; Lau YL
    Vaccine; 2007 Sep; 25(39-40):6837-41. PubMed ID: 17714837
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Sinusitis and pneumonia hospitalization after introduction of pneumococcal conjugate vaccine.
    Lindstrand A; Bennet R; Galanis I; Blennow M; Ask LS; Dennison SH; Rinder MR; Eriksson M; Henriques-Normark B; Ortqvist A; Alfvén T
    Pediatrics; 2014 Dec; 134(6):e1528-36. PubMed ID: 25384486
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: South Africa, 2003-2008.
    von Gottberg A; Cohen C; de Gouveia L; Meiring S; Quan V; Whitelaw A; Crowther-Gibson P; Madhi SA; Whitney CG; Klugman KP
    Vaccine; 2013 Aug; 31(38):4200-8. PubMed ID: 23684826
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Early impact of pneumococcal conjugate vaccine on invasive pneumococcal disease in Singapore children, 2005 through 2010.
    Thoon KC; Chong CY; Tee NW
    Int J Infect Dis; 2012 Mar; 16(3):e209-15. PubMed ID: 22281191
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pneumococcal meningitis trends after pneumococcal conjugate vaccine introduction in Colombia: An interrupted time-series analysis.
    Caceres DC; Ortega-Barria E; Nieto J; DeAntonio R
    Hum Vaccin Immunother; 2018 May; 14(5):1230-1233. PubMed ID: 29351491
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The preventable burden of pneumococcal disease in the developing world.
    Scott JA
    Vaccine; 2007 Mar; 25(13):2398-405. PubMed ID: 17028081
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Changes in Invasive Pneumococcal Disease Spectrum After 13-Valent Pneumococcal Conjugate Vaccine Implementation.
    Levy C; Varon E; Ouldali N; Béchet S; Bonacorsi S; Cohen R
    Clin Infect Dis; 2020 Jan; 70(3):446-454. PubMed ID: 30869777
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pneumococcal meningitis: epidemiological profile pre- and post-introduction of the pneumococcal 10-valent conjugate vaccine.
    Hirose TE; Maluf EM; Rodrigues CO
    J Pediatr (Rio J); 2015; 91(2):130-5. PubMed ID: 25451210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.